Skip Page Header

Home > Financial case for action on liver disease. Escalating costs of alcohol misuse, obesity and viral hepatitis.

Foundation for Liver Research. (2017) Financial case for action on liver disease. Escalating costs of alcohol misuse, obesity and viral hepatitis. London: Foundation for Liver Research.

[img]
Preview
PDF (Financial case for action on liver disease)
406kB

Liver disease has grown to become one of the most common causes of premature death in the UK and its burden continues to escalate. 62,000 years of working life are lost to liver disease every year and its impact on the poorest in our society is disproportionally severe, contributing to the widening of socioeconomic health inequalities in the UK.

 

Worsening liver disease health outcomes could be reversed through concerted preventive action to tackle its main causes: alcohol misuse, obesity and viral hepatitis. Voluntary agreements with the food and drinks and alcohol industries have proved ineffective.

 

Through this paper, the Foundation for Liver Research seeks to make the financial case for public health action in these areas and urges the implementation of targeted measures recommended by the independent Lancet Commission on Liver Disease. This paper summarises the escalating financial costs to the health and care system as well as the wider societal costs related to the three lifestyle-related risk factors.

Repository Staff Only: item control page